Alcohol Intake and Esophageal Cancer: Epidemiologic Evidence

Author(s):  
Jill Layton ◽  
Jianjun Zhang
1988 ◽  
Vol 4 (1) ◽  
pp. 93-98 ◽  
Author(s):  
F. La Rosa ◽  
A. Cresci ◽  
C. Orpianesi ◽  
G. Saltalamacchia ◽  
V. Mastrandrea

2004 ◽  
Vol 113 (3) ◽  
pp. 475-482 ◽  
Author(s):  
Chien-Hung Lee ◽  
Jang-Ming Lee ◽  
Deng-Chyang Wu ◽  
Hon-Ki Hsu ◽  
Ein-Long Kao ◽  
...  

2020 ◽  
Vol 55 (5) ◽  
pp. 457-467
Author(s):  
Xiaohui Yu ◽  
Jiahao Chen ◽  
Wenjie Jiang ◽  
Dongfeng Zhang

Abstract Aims We conducted a dose–response meta-analysis to explore the association between alcohol and particular alcoholic beverages with risk of esophageal cancer (EC) by histological type [esophageal squamous cell carcinoma (ESCC) and esophageal adenocarcinoma (EAC)] and whether the association differs according to gender. Methods PubMed and Web of Science databases were searched for relevant articles published between January 1960 and December 2019. The pooled relative ratios (RRs) and 95% confidence interval (CI) were calculated with the fixed or random effect model. The dose–response relationship was assessed by restricted cubic spline. Results A total of 74 published articles involving 31,105 cases among 3,369,024 participants were included in this meta-analysis. The pooled RRs of the highest versus lowest alcohol intake were 3.67 (95% CI, 2.89,4.67) for EC, 5.11 (95% CI, 3.60,7.25) for ESCC and 0.96 (95% CI, 0.79,1.16) for EAC. The above-mentioned associations were observed in cohort design, for different alcoholic beverages (beer, wine and liquor/spirits) and gender. Evidence of a nonlinear dose–response relationship for EC risk with alcohol intake was found (Pnon-linearity < 0.001), and a linear relationship (Pnon-linearity = 0.216) suggested that the risk of ESCC increased by 33% for every 12.5 g/day increment of alcohol intake. Conclusions This meta-analysis suggests that alcohol intake might significantly increase the incidence of EC, especially for ESCC.


2016 ◽  
Vol 1 (13) ◽  
pp. 169-176
Author(s):  
Lisa M. Evangelista ◽  
James L. Coyle

Esophageal cancer is the sixth leading cause of death from cancer worldwide. Esophageal resection is the mainstay treatment for cancers of the esophagus. While curative, surgical resection may result in swallowing difficulties that require intervention from speech-language pathologists (SLPs). Minimally invasive surgical procedures for esophageal resection have aimed to reduce morbidity and mortality associated with more invasive techniques. Both intra-operative and post-operative complications, regardless of the surgical approach, can result in dysphagia. This article will review the epidemiological impact of esophageal cancers, operative complications resulting in dysphagia, and clinical assessment and management of dysphagia pertinent to esophageal resection.


Sign in / Sign up

Export Citation Format

Share Document